Review sheds light on the mechanistic role of long non-coding RNAs in liver disease

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a global health challenge, affecting nearly 30% of adults worldwide.

Five Weeknight Dishes: The (quick) dinners I wait all year to make – The Cannabist

By Ali Slagle, The New York Times I spend most days tinkering with new recipes, so when it’s time to eat dinner, there are usually

July 23, 2024

FDA rejects motion sickness drug from Defender Pharma

Government-partnered Defender Pharmaceuticals received an FDA rejection Tuesday for its motion sickness prevention drug. “We plan on scheduling a formal meeting with the FDA to

January 31, 2024

Sanofi introduces new 340B payment model — report

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.